Quarterly Results

  • Company Name :
Anthem Biosciences Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 544449
  • NSE Symbol:
  • ANTHEM
  • P/E(TTM):
  • 62.20
  • ISIN Demat:
  • INE0CZ201020
  • Div & Yield%:
  • 0.00
  • EPS(TTM):
  • 12.22
  • Book Value(₹):
  • 56.55
  • Market Cap(₹Cr.):
  • 42,808.46
  • Face Value(₹):
  • 2.00
Quarters :  
Particulars March 2026 ( Cr)December 2025 ( Cr)September 2025 ( Cr)
Gross Sales 582.50 416.58 552.23
Excise Duty 0.00 0.00 0.00
Net Sales 582.50 416.58 552.23
Other Operating Income 0.00 0.00 0.00
Other Income 61.60 39.92 53.80
Total Income 644.10 456.50 606.03
Total Expenditure 315.51 278.51 326.57
PBIDT 328.59 177.98 279.45
Interest 1.58 1.13 2.23
PBDT 327.01 176.86 277.22
Depreciation 26.28 26.75 23.92
Tax 89.71 37.78 63.75
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax -0.65 0.21 -8.88
Reported Profit After Tax 211.67 112.12 198.43
Extra-ordinary Items 0.68 -18.66 0.00
Adjusted Profit After Extra-ordinary item 210.99 130.78 198.43
EPS (Unit Curr.) 3.77 2.00 3.54
EPS (Adj) (Unit Curr.) 3.77 2.00 3.54
Calculated EPS (Unit Curr.) 3.77 2.00 3.53
Calculated EPS (Adj) (Unit Curr.) 3.77 2.00 3.53
Calculated EPS (Ann.) (Unit Curr.) 15.07 7.99 14.13
Calculated EPS (Adj) (Ann.) (Unit Curr.) 15.07 7.99 14.13
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 112.34 112.32 112.32
Reserve & Surplus 0.00 0.00 0.00
Face Value 2.00 2.00 2.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 56.41 42.72 50.60
PBDTM(%) 56.14 42.46 50.20
PATM(%) 36.34 26.91 35.93